| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 125 |
| 1 | PREDNISONE | 66 |
| 2 | PREDNISOLONE | 60 |
| 3 | PREDNISOLONE ORAL | 60 |
| 4 | PREDNISOLONE ORAL SOLUTION | 60 |
| 5 | DEXAMETHASONE | 51 |
| 6 | DEXAMETHASONE 1.5 MG | 51 |
| 7 | CARBOPLATIN | 49 |
| 8 | FLUOROURACIL | 49 |
| 9 | IBUPROFEN | 49 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROPHOR | 1 | 0.0556 |
| 1 | ADENINE | 1 | 0.0204 |
| 2 | VITAMINS AND MINERALS | 1 | 0.0112 |
| 3 | CARBON DIOXIDE | 1 | 0.0087 |
| 4 | ERYTHROMYCIN LACTOBIONATE | 1 | 0.0068 |
| 5 | FLOXURIDINE | 1 | 0.0058 |
| 6 | EPHEDRINE SULFATE | 1 | 0.0046 |
| 7 | CAMPHOR, EUCALYPTUS OIL, MENTHOL | 1 | 0.0043 |
| 8 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE | 1 | 0.0042 |
| 9 | MIRVETUXIMAB SORAVTANSINE | 5 | 0.0028 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 5 | 0.0017 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 8 | 0.0013 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 126 | 0.0007 |
| 3 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 4 | alpha-Glucosidase Inhibitor [EPC] | 3 | 0.0006 |
| 5 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 6 | Echinocandin Antifungal [EPC] | 4 | 0.0005 |
| 7 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 8 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 9 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |